Taikang Insurance Group to increase its stake in Han Xi

Published: 2019年11月14日

Recently, Taikang Insurance Group to increase capital shares Han Xintai and strategic cooperation signing ceremony held in Beijing. This marks the Taikang Insurance Group to complete the increase in the shares of Han Xi Putai, and the latter in the field of health to achieve strategic cooperation. Sequoia Capital China Fund, China Everbright Holdings and other representatives of the shareholders and a number of cardiovascular experts witnessed the signing ceremony.

Tai Hong Insurance Group Chairman and Chief Executive Officer Chen Dongsheng pointed out that Taikang is committed to focus on "insurance, management, health care" to create eco-industrial chain, with huge stock customers, sales network and other resources, will give Han Xi Pu Tai Bring a lot of added value. "Han Xi Putai by virtue of strength has been the international and domestic well-known investment institutions of all ages, we respect the founder and management team, as one of the important investors, we invest in excellent management team, leading professional and technical, through the power of capital, Through the customer, sales network and other market forces, to create our health care of the ecological chain, the Han Xi Pu Tai to build the first brand in the cardiovascular field, in the chain of cardiovascular specialist hospital to become the best hospital. "Chen Dongsheng said. From 1996 to 2016, Taikang Insurance Group in the tide of reform and opening up due to time, due to the city and Xing, due to change, adhere to deep life chain industry chain, from a single life insurance company, to the big health as the core Innovative Insurance Financial Services Group has made great strides forward. The capital increase Hanci Putai, and Taikang's development strategy the same strain.

"The distribution of medical resources in the cardiovascular sector is very uneven, a large number of high-quality resources concentrated in a few large cities, more cities in this area of diagnosis and treatment level is difficult to meet market demand.Facing the market a huge opportunity, Years ago found and invested in the Han Xi Pu Tai, Han Xi Pu Tai has been attracting Medtronic, Everbright and other first-class industry investors.Hangxi Putai has been from the early development of light asset model to the full range of cardiovascular chain hospital Model, and a number of useful attempts in the field of cardiovascular derivatives. "Sequoia Capital China Fund founder and Sequoia Capital Global Executive Partner Shen Nanpeng at the signing ceremony to review the Sequoia China investment Han Xipu's logic.

China Everbright Holdings Chief Executive Officer, CEO Chen Shuang said that Taikang shares will give Han Xi Putai future development to bring more space. "Including Hanxi Putai, Everbright Holdings has done a lot of investment in the medical aspects of investment from the development of the situation, we see the entrepreneurial spirit of the future we will work together with the founder and management team to Hanxi Putai's career to do. "Chen Shuang said.

Han Xi Putai Chairman Hao Jiansheng said that Han Xi medical treatment by the cardiovascular field of a number of experts and management team to create, the enterprise's genes determine the Han Xi Pu Tai is taking the medical services and hospital management path, The establishment of the expert resources as the basis, equity investment and management and management of the cardiovascular chain system business model, has been holding a number of cardiovascular hospitals, began to enter the field of rehabilitation last year, operated by the two rehabilitation hospitals will also be invested this year Operating. Hao Jiansheng on Taikang shares after the Han Xi Putai full of confidence: "Taikang and Han Xi together to extend the development of both sides of the space, the future will jointly develop medical services and insurance areas of mutual integration and common development of new ideas and new models.